Need Help?
Copied to clipboard!

Genomic Landscape of Pediatric Myelodysplastic Syndromes

Pediatric myelodysplastic syndromes (MDS) are a rare disease and unlike their adult counterpart, very little is known about their genomic landscape. We characterized a cohort of patients from a single institution by whole exome sequencing, as well as a subset of patients by whole genome sequencing, RNA-sequencing and targeted deep sequencing. We found a spectrum of mutations, both somatic and germline, that are distinct from those observed in adult MDS. In turn, we observed mutations commonly observed in other pediatric myeloid tumors.

Cite

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001003155 Illumina HiSeq 2000 6
EGAD00001003156 Illumina HiSeq 2000 4
EGAD00001003781 Illumina HiSeq 2000 94
EGAD00001003782 Illumina HiSeq 2000 43
Publications Citations
Germline SAMD9 mutation in siblings with monosomy 7 and myelodysplastic syndrome.
Leukemia 31: 2017 1827-1830
62
The genomic landscape of pediatric myelodysplastic syndromes.
Nat Commun 8: 2017 1557
159
Clonal dynamics of donor-derived myelodysplastic syndrome after unrelated hematopoietic cell transplantation for high-risk pediatric B-lymphoblastic leukemia.
Cold Spring Harb Mol Case Stud 4: 2018 a002980
5
Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes.
JCI Insight 3: 2018 121086
80
Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
Nat Commun 14: 2023 1739
27